Triazole compounds that modulate HSP90 activity
US9126953B2 · kind B2 · utility
6Cited by
24References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 2009 |
| Grant date | Sep 8, 2015 |
| Priority date | — |
| Expiry date | May 31, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to substituted pyrrole compounds of formula I and compositions comprising substituted tri-substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a tri-substituted’ triazole compound of the invention, or a pharmaceutical composition comprising such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.